カルナバイオサイエンス(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4572/E00987Carna Biosciences,Inc.
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2021/12/24日証協無担保2,000株+17.65%0株0%17,105株+755.25%
2021/12/24日証協有担保392,895株+1393.9%600株0%133,306株+25.25%
2021/12/17日証協無担保1,700株+325%0株0%2,000株+81.82%
2021/12/17日証協有担保26,300株-81.48%0株0%106,434株+4.55%
2021/12/10日証協無担保400株-73.33%0株0%1,100株-67.65%
2021/12/10日証協有担保142,016株-38.2%0株0%101,801株+13.03%
2021/12/03日証協無担保1,500株-31.82%0株0%3,400株-24.44%
2021/12/03日証協有担保229,816株-19.87%0株0%90,067株-31.66%
2021/11/26日証協無担保2,200株0%0株0%4,500株+55.17%
2021/11/26日証協有担保286,800株-2.38%0株-100%131,801株+145.44%
2021/11/19日証協無担保0株-100%0株0%2,900株-19.6%
2021/11/19日証協有担保293,800株+25.77%100株-99.73%53,700株-18.88%
2021/11/05日証協無担保200株0%0株0%3,500株-25.53%
2021/11/05日証協有担保129,800株+23.03%2,800株-93.53%11,400株+147.83%
2021/10/29日証協無担保0株0%0株0%4,700株-41.25%
2021/10/29日証協有担保105,500株-23.38%43,300株+0.23%4,600株+253.85%
2021/10/22日証協無担保0株-100%0株0%8,000株+95.12%
2021/10/22日証協有担保137,701株+9.81%43,200株+500%1,300株-35%
2021/10/15日証協無担保100株-87.5%0株0%4,100株+51.52%
2021/10/15日証協有担保125,400株+57.93%7,200株-35.14%2,000株-89.47%
2021/10/08日証協無担保800株-98.56%0株0%2,706株-66.59%
2021/10/08日証協有担保79,400株-37.28%11,100株-71.9%19,000株-93.52%
2021/10/01日証協無担保55,500株+9999.99%0株0%8,100株+145.38%
2021/10/01日証協有担保126,600株-13.29%39,500株+130.99%293,200株+299.46%
2021/09/24日証協無担保100株-94.44%0株0%3,301株-85.95%
2021/09/24日証協有担保146,000株-34.06%17,100株-88.93%73,400株-8.44%
2021/09/17日証協無担保1,800株+200%0株0%23,503株+179.63%
2021/09/17日証協有担保221,400株-28.48%154,500株+503.52%80,170株-28.29%
2021/09/10日証協無担保600株+200%0株0%8,405株+5.05%
2021/09/10日証協有担保309,572株+157.7%25,600株-78.31%111,800株+2384.44%
2021/09/03日証協無担保200株-77.78%0株0%8,001株-43.28%
2021/09/03日証協有担保120,128株-11.21%118,000株+352.11%4,500株-95.81%
2021/08/27日証協無担保900株+800%0株0%14,105株-78.13%
2021/08/27日証協有担保135,300株-28.94%26,100株-3.33%107,300株+92.99%
2021/08/20日証協無担保100株-85.71%0株0%64,500株+3483.33%
2021/08/20日証協有担保190,400株-77.3%27,000株-55.45%55,600株-24.15%
2021/08/13日証協無担保700株+75%0株0%1,800株-67.86%
2021/08/13日証協有担保838,634株+430.45%60,600株+240.45%73,300株-82.12%

※株式分割は考慮していませんのでご注意ください。

Page Top